Breast Cancer Cell Line Protocols

Details on breast cancer cell lines and culture conditions are presented in the Supplementary material. TRA-8 antibody (mouse IgG1 isotype) was prepared at the University of Alabama at Birmingham [15 (link)]. Doxorubicin was obtained from Polymed Therapeutics (Houston, TX). Paclitaxel was from Sigma Aldrich Chemical Co. (St. Louis, MO). Abraxane was from the University of Alabama at Birmingham Hospital Pharmacy.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Oliver P.G., LoBuglio A.F., Zhou T., Forero A., Kim H., Zinn K.R., Zhai G., Li Y., Lee C.H, & Buchsbaum D.J. (2011). Effect of anti-DR5 and chemotherapy on basal-like breast cancer. Breast cancer research and treatment, 133(2), 417-426.

Publication 2011

Abraxane Antibody Breast cancer cell lines Doxorubicin Igg1 Isotype Mouse Paclitaxel Therapeutics Tra 8

Corresponding Organization :

Other organizations : University of Alabama at Birmingham

Top 5 similar protocols

Protocol cited in 4 other protocols

Variable analysis

independent variables

TRA-8 antibody (mouse IgG1 isotype)

dependent variables

Not explicitly mentioned

control variables

Breast cancer cell lines and culture conditions (details presented in Supplementary material)
Doxorubicin (from Polymed Therapeutics, Houston, TX)
Paclitaxel (from Sigma Aldrich Chemical Co., St. Louis, MO)
Abraxane (from the University of Alabama at Birmingham Hospital Pharmacy)

positive controls

Not specified

negative controls

Not specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!